Grade: Pharmaceutical Grade

Factory Location: Lianyungang Jiangsu China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Etoposide or VP-16 is a cytotoxic anticancer drug which belongs to thetopoisomerase inhibitor drug class. It is used as a form of chemotherapy for cancers such as Kaposi’s sarcoma, Ewing's sarcoma, lung cancer, testicular cancer, lymphoma, nonlymphocytic leukemia, and glioblastoma multiforme. It is often given in combination with other drugs (such as bleomycin in treating testicular cancer). It is also sometimes used in a conditioning regimen prior to a bone marrow or blood stem cell transplant.
This API product has been approved by US-FDA, has Chinese local GMP and CEP certificate.
Etoposide Injection and Etoposide Soft Capsules have Chinese local GMP certificate.